Bixiye
QP15-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 14, 2022
Taariikhda uu dhaqangalayo Barnaamijka: 23, Feb 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2001 - 2010 ee natiijooyinka 3167
Bixiye
QP8-22 Anthem Blue Cross Change to City of New York Retirees
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP9-22 Timely Filing Denials for COVID-19 Testing and Immunizations
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP10-22 Commercial Pharmacy Benefit Exclusion for Basaglar®
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP11-22 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP12-22 MHCP Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP13-22 Commercial Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
P5-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P6-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P7-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022